We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SPB:NYSESpectrum Brands Holdings, Inc. Analysis

Data as of 2026-05-02 - not real-time

$82.96

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Spectrum Brands (SPB) trades at $82.96, comfortably above its 20‑day ($81.42) and 50‑day ($77.86) moving averages, confirming a bullish price trend. The 14‑day RSI sits at 59, indicating modest upward momentum without being overbought. Although the MACD histogram is slightly negative, the divergence is small and the overall trend remains bullish. Volatility over the past 30 days is elevated at roughly 32%, while the stock’s beta of 0.8 suggests it moves less than the market. The company yields 2.27% dividend with a payout ratio of 44%, supported by free cash flow of $242 M. Recent announcements of a $300 M share‑repurchase program and accelerated digital and brand investments aim to lift margins and drive growth.
Fundamentally, SPB’s forward PE of 15.4 and price‑to‑book of 1.02 place it near fair value, and the DCF‑derived fair price of $113.98 implies modest upside beyond the consensus target of $85. The balance sheet shows $697 M debt versus $127 M cash, yielding a debt‑to‑equity of 36.7%, which is manageable given stable operating cash flow. With a modest ROE of 5.3% and operating margin of 4.5%, earnings growth is modest but the cost‑cutting initiatives should improve profitability. The “Extreme Greed” sentiment index reflects strong market optimism. Overall, the stock appears fairly valued with limited upside in the near term but attractive long‑term fundamentals.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price trading above short‑term moving averages
  • Slightly bearish MACD histogram
  • Elevated short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Share‑repurchase program signaling confidence
  • Cost‑cutting and digital investment improving margins
  • Forward PE of 15.4 indicating reasonable valuation

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value suggesting upside
  • Sustainable dividend yield and payout ratio
  • Diversified global consumer‑defensive portfolio

Key Metrics & Analysis

Financial Health

Revenue Growth-3.30%
Profit Margin3.76%
P/E Ratio19.6
ROE5.35%
ROA2.66%
Debt/Equity36.73
P/B Ratio1.0
Op. Cash Flow$343.4M
Free Cash Flow$241.9M

Technical Analysis

TrendBullish
RSI59.0
Support$72.12
Resistance$85.49
MA 20$81.42
MA 50$77.86
MA 200$63.26
MACDBearish
VolumeStable
Fear & Greed Index91.09

Valuation

Fair Value$113.98
Target Price$85.29
Upside/Downside2.80%
GradeFair
TypeBlend
Dividend Yield2.27%

Risk Assessment

Beta0.80
Volatility31.71%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.